<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
	<Article>
		<Journal>
			<PublisherName/>
			<JournalTitle>IJOTM</JournalTitle>
			<Issn>2008-6490</Issn>
			<Volume>1</Volume>
			<Issue>2</Issue>
			<PubDate PubStatus="epublish">
				<Year>2010</Year>
				<Month>03</Month>
				<Day>31</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>The Impact of Hepatitis B Infection on Outcome of Kidney Transplantation: A Long-Term Study</ArticleTitle>
		<FirstPage>91</FirstPage>
		<LastPage>93</LastPage>
		<Language>EN</Language>
		<AuthorList>
			<Author>
				<FirstName>B</FirstName>
				<LastName>Einollahi</LastName>
				<Affiliation>Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. einollahi@inu.ir</Affiliation>
			</Author>
			<Author>
				<FirstName>S</FirstName>
				<MiddleName>M</MiddleName>
				<LastName>Alavian</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<LastName>Lessan-Pezeshki</LastName>
			</Author>
			<Author>
				<FirstName>N</FirstName>
				<LastName>Simforoosh</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<MiddleName>H</MiddleName>
				<LastName>Nourbala</LastName>
			</Author>
			<Author>
				<FirstName>Z</FirstName>
				<LastName>Rostami</LastName>
			</Author>
			<Author>
				<FirstName>V</FirstName>
				<LastName>Pourfarziani</LastName>
			</Author>
			<Author>
				<FirstName>E</FirstName>
				<LastName>Nemati</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<LastName>Sharafi</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<LastName>Nafar</LastName>
			</Author>
			<Author>
				<FirstName>F</FirstName>
				<LastName>Pour-Reza Gholi</LastName>
			</Author>
			<Author>
				<FirstName>A</FirstName>
				<LastName>Firoozan</LastName>
			</Author>
		</AuthorList>
		<History>
			<PubDate PubStatus="received">
				<Year>2010</Year>
				<Month>03</Month>
				<Day>31</Day>
			</PubDate>
		</History>
		<Abstract>Background: With the success of kidney transplantation, liver disease has emerged as an important cause of morbidity and mortality in kidney recipients.Objective: To determine the impact of hepatitis B virus (HBV) infection on patients and graft survival in both short- and long-terms.Methods: 99 renal transplant patients infected with HBV on follow-up in two major transplant centers were included in a retrospective study. These patients were grafted between 1986 and 2005 and divided into two groups: (1) those only positive for hepatitis B surface antigen (HBsAg) and (2) those who were also positive for hepatitis C virus antibodies (HCV Ab).Results: There were 88 patients with HBsAg+ and 11 with both HBsAg+ and HCV Ab+. The mean&amp;plusmn;SD age of patients was 38.8&amp;plusmn;13.2 years, and the median follow-up after transplantation was 19 months. Although not significant, the allograft survival rate in the first group (HBV+) was better compared to that in the second group (HBV+ and HCV+); 1, 5 and 10 years graft survival rates were 91, 77 and 62 in the first group and 70, 56 and 28 in the second group, respectively (P=0.07). The overall mortality was 5% (4 of 88) in the first and 27% (3 of 11) in the second group (P=0.02).Conclusion: Renal allograft recipients with HBV and HCV infections has a poor survival rate compared to patients with only HBV infection. However, there is no significant difference in terms of renal graft survival between the two groups.</Abstract>
	</Article>
</ArticleSet>
